Claims
- 1. A process for reducing blood pressure and blocking .beta.-adrenergic receptor, which comprises the administration of an effective amount of a composition comprising as its active ingredient a 1-(3,4-methylenedioxyphenyl)-2-alkylaminoethanol compound represented by the formula: ##STR20## wherein R is an alkyl group having 2 to 6 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
- 2. The process according to claim 1, wherein the active ingredient is 1-(3,4-methylenedioxyphenyl)-2-isopropylaminoethanol.
- 3. The process according to claim 1, wherein the active ingredient is 1-(3,4-methylenedioxyphenyl)-2-t-butylaminoethanol.
- 4. The process according to claim 1 wherein said active ingredient is in the form of a pharmaceutically acceptable acid addition salt selected from the group consisting of oxalate, lactate, tartrate, naphthoate, acetate, salicylate, citrate, benzoate, adipate, and maleate.
- 5. The process according to claim 1 wherein said active ingredient is in the form of a pharmaceutically acceptable acid addition salt selected from the group consisting of hydrochloride, hydrobromide, phosphate and sulfate.
- 6. The process according to claim 1 wherein said active ingredient is 1-(3,4-methylenedioxyphenyl)-2-isopropylaminoethanol hydrochloride.
- 7. The process according to claim 1 wherein said active ingredient is 1-(3,4-methylendioxyphenyl)-2-ethylaminethanol hydrochloride.
- 8. The process according to claim 1 wherein said active ingredient is 1-(3,4methylenedioxyphenyl)-2-t-butylaminoethanol hydrochloride.
Priority Claims (3)
Number |
Date |
Country |
Kind |
46-45206 |
Jun 1971 |
JP |
|
46-45207 |
Jun 1971 |
JP |
|
46-47148 |
Jun 1971 |
JP |
|
Parent Case Info
This is a continuation, of application Ser. No. 264,336, filed June 19, 1972, and now abandoned.
US Referenced Citations (4)
Continuations (1)
|
Number |
Date |
Country |
Parent |
264336 |
Jun 1972 |
|